Negative regulation of TCR-associated PTKs
Negative regulation of TCR-associated PTKs
批准号:
6824908
负责人:
Tomas M Mustelin
金额:
$48.0万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-06-15 至 2007-11-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
EXCEED THE SPACE PROVIDED. Tyrosine phosphorylation is a key mechanism for transmitting growth signals into cells. In T lymphocytes, both the T cell antigen receptor (TCR) and the receptor for the growth factor interleukin-2 (IL-2) use multiple well known protein tyrosine kinases (PTKs) for signaling. In contrast, very little is known about the protein tyrosine phosphatases (PTPases) that counteract these PTKs by dephosphorylating them and their substrates. This proposal focuses on the PEP PTPase and the Csk PTK, which form a complex that negatively regulates early TCR signaling events. 1) First, we will generate and analyze PEP-/-, antigen-specific, CD4+ and CD8+ T cells by crossing PEP knock-out mice with TCR transgenic animals. We will also generate PEP-/- clones of the Jurkat T leukemia cell line by a novel somatic gene deletion technology. We will determine to what extent TCR signaling is altered in the absence of PEP and if Lck and Fyn are hyperactive. As a control, we will use the IL-2R system to test the notion that PTKs that do not depend on Src family kinases, such as Jakl and Jak3, are insensitive to loss of PEP. 2) Second, we will use the PEP-l- T cells to gain some insight into the structure-function relationships, specificity, and subcellular targeting of the PEP-Csk complex to lipid rafts or two interacting proteins, PAG/Cbp and G3BP. 3) Third, we will continue to study our finding that PKA phosphorylates Csk at serine 364 ($364) in vitro as well as in intact T cells and thereby activates Csk 3- to 5-fold. This activation results in increased suppression of Lck and reduced TCR signaling. We will investigate whether PEP is also directly phosphorylated at $35 and regulated by PKA. The molecular mechanism by which PEP is regulated will also be examined. 4) Fourth, we will undertake a number of structural studies and will attempt to solve the crystal structure of individual domains and their complexes, ultimately hoping to understand the structure of the whole enzymes and even their complex. These studies are particularly important ifor understanding the regulation of PEP and the impact of PKA-mediated phosphorylation of Csk at $364. Overall, these studies will provide a detailed characterization of the function and structure of PEP and Csk from the level of physiological relevance in whole animals to atomic structure and regulation. These issues are important for our understanding of the molecular machinery of T cell activation and the immune response. PERFORMANCE SITE ========================================Section End===========================================
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of the L1 retrotransposon in interferon-positive SLE
-
批准号:10603189
-
项目类别:
-
资助金额:$54.75万
-
财政年份:2022
-
负责人:Tomas M Mustelin
-
依托单位:
HERV-K immunity, a trigger of citrullination in rheumatoid arthritis?
-
批准号:10402763
-
项目类别:
-
资助金额:$19.22万
-
财政年份:2021
-
负责人:Tomas M Mustelin
-
依托单位:
Role of protein citrullination in rheumatoid arthritis
-
批准号:10548134
-
项目类别:
-
资助金额:$38.83万
-
财政年份:2020
-
负责人:Tomas M Mustelin
-
依托单位:
Role of protein citrullination in rheumatoid arthritis
-
批准号:9883195
-
项目类别:
-
资助金额:$38.83万
-
财政年份:2020
-
负责人:Tomas M Mustelin
-
依托单位:
Role of protein citrullination in rheumatoid arthritis
-
批准号:10091400
-
项目类别:
-
资助金额:$37.67万
-
财政年份:2020
-
负责人:Tomas M Mustelin
-
依托单位:
Role of protein citrullination in rheumatoid arthritis
-
批准号:10318576
-
项目类别:
-
资助金额:$38.44万
-
财政年份:2020
-
负责人:Tomas M Mustelin
-
依托单位:
The roots of SLE: Can we cure it with a reverse transcriptase inhibitor?
-
批准号:9922870
-
项目类别:
-
资助金额:$19.42万
-
财政年份:2019
-
负责人:Tomas M Mustelin
-
依托单位:
CORE 3C: INFRASTRUCTURE PROTEOMICS
-
批准号:7725965
-
项目类别:
-
资助金额:$12.13万
-
财政年份:2008
-
负责人:Tomas M Mustelin
-
依托单位:
CORE 3C: INFRASTRUCTURE PROTEOMICS
-
批准号:7622863
-
项目类别:
-
资助金额:$11.62万
-
财政年份:2007
-
负责人:Tomas M Mustelin
-
依托单位:
CORE 3C: INFRASTRUCTURE PROTEOMICS
-
批准号:7380834
-
项目类别:
-
资助金额:$12.53万
-
财政年份:2006
-
负责人:Tomas M Mustelin
-
依托单位:
CORE 3C: INFRASTRUCTURE PROTEOMICS
-
批准号:7167090
-
项目类别:
-
资助金额:$11.24万
-
财政年份:2005
-
负责人:Tomas M Mustelin
-
依托单位:
CORE--Shared Resources Proteomics
-
批准号:6990469
-
项目类别:
-
资助金额:$11.08万
-
财政年份:2004
-
负责人:Tomas M Mustelin
-
依托单位:
Cell Death Induced by Yersinia YopH
-
批准号:6800912
-
项目类别:
-
资助金额:$32.36万
-
财政年份:2004
-
负责人:Tomas M Mustelin
-
依托单位:
PTP-MEG2: Regulation, Substrates, Biology
-
批准号:6844731
-
项目类别:
-
资助金额:$33.43万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
Regulation of the tumor suppressor PTEN
-
批准号:7004490
-
项目类别:
-
资助金额:$33.37万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
Negative regulation of TCR-associated PTKs
-
批准号:6983414
-
项目类别:
-
资助金额:$46.87万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
Regulation of the tumor suppressor PTEN
-
批准号:6839424
-
项目类别:
-
资助金额:$34.18万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
Regulation of the tumor suppressor PTEN
-
批准号:6581980
-
项目类别:
-
资助金额:$34.18万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
Regulation of the tumor suppressor PTEN
-
批准号:6694027
-
项目类别:
-
资助金额:$34.18万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
PTP-MEG2: Regulation, Substrates, Biology
-
批准号:7008879
-
项目类别:
-
资助金额:$32.64万
-
财政年份:2003
-
负责人:Tomas M Mustelin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
精氨酸调控骨髓Tregs稳态在脓毒症骨髓功能障碍中的作用研究
-
批准号:82371770
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:宁铂涛
-
依托单位:
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
-
批准号:82371801
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:周海波
-
依托单位:
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
-
批准号:82371028
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵慧
-
依托单位:
亚低温调控颅脑创伤急性期神经干细胞Mpc2/Lactate/H3K9lac通路促进神经修复的研究
-
批准号:82371379
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:冯军峰
-
依托单位:
α-酮戊二酸调控ACMSD介导犬尿氨酸通路代谢重编程在年龄相关性听力损失中的作用及机制研究
-
批准号:82371150
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯书乐
-
依托单位:
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
-
批准号:82372275
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘耀宝
-
依托单位:
mPFC-VTA-NAc多巴胺能投射调控丙泊酚麻醉—觉醒的机制研究
-
批准号:82371284
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:许涛
-
依托单位: